IR News
This document provides integrated information to the media. In some instances, information on products or drug candidates under development may be included, but this is intended for members of the media, shareholders, and investors. The information is not intended for promotional or advertising purposes, or as medical advice, etc.
-
CompanyJCR Pharmaceuticals Launches Redesigned Corporate Website
-
CompanyAnnouncement of Executive Appointments and Organizational Changes
-
CompanyJCR Establishes Advanced Biopharmaceutical Research Institute
-
SustainabilityJCR Pharmaceuticals Supports Rare Disease Day 2026
-
OtherJCR Organizes and Conducts API Plant Tour for Individual Shareholders
-
Research & DevelopmentJCR Pharmaceuticals’ Research Presentations at WORLDSymposium 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
-
Management & FinanceFY2025 Third Quarter Results Briefing Session - Script
-
Management & FinanceFY2025-Q3 Financial Report (Oct. 1-Dec. 31, 2025)
-
Management & FinanceRevision of Consolidated Financial Forecasts for Fiscal Year Ended March 31, 2026
-
Management & FinanceRecognition of Subsidy Income as Extraordinary Income